Navigation Links
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
Date:9/24/2007

Data Safety Monitoring Board (DSMB) Authorizes Enrollment of Cervical

Patients at Current Highest Authorized Dosage Level

HOPKINTON, Mass., Sept. 24 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals (Nasdaq: ALSE) today announced that its independent Data Safety Monitoring Board (DSMB) has unanimously authorized expanding the Company's Phase I/IIa clinical trial in acute spinal cord injury (SCI) to allow subjects with cervical SCI to be treated with a 9 mg dose of Cethrin(R). This recommendation is based on the safety analyses of data from thoracic subjects who have been treated at the 9mg dosage level and overall evaluation of safety of the drug in this clinical trial to date.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

In this clinical trial each dose level is first given to thoracic SCI subjects and then, following review by the DSMB, the dose level is extended to cervical subjects. Authorization to administer a 9 mg dose in this clinical trial was given by the U.S. Food and Drug Administration in June 2007 and earlier by Health Canada. Cervical spinal cord injuries occur in the vertebrae of the neck and often result in quadriplegia; thoracic spinal injury occurs in the region of the back between the neck and the pelvis often resulting in paraplegia.

Alseres' DSMB is composed of independent medical and statistical experts who evaluate the safety of the clinical trial being conducted at 9 sites in the US and Canada. The Company expects enrollment in the trial to conclude by the end of 2007.

"The DSMB's recommendation is an important step in the Cethrin clinical plan," c
'/>"/>

SOURCE Alseres Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABA...t-of-care blood analysis systems, announced today ...officer, will present at the 21st Annual Piper Jaf... 2, 2009 at 2:00 p.m. ET. The conference will be h... ,, About Abaxis ,, Abaxis develops, manu...
(Date:11/25/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Pain Management - Global Trends ,,...ment---Global-Trends.html ,, Widespread availa...ent clinics, and the advent of new drugs have acce...market. Healthcare reforms and reimbursement struc...
(Date:11/24/2009)...24 /PRNewswire-Asia/ -- Chindex International, Inc...ent American provider of Western,healthcare produc... today,announced that the Company will attend the ...Conference, to be held December 1 - 2, 2009, at th...currently scheduled to present at 11:30 am ET on T...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Chindex International to Present at Piper Jaffray Health Care Conference 2EyeScience 28TM 29 Announces New Program to Improve Patient Compliance and Practice Profits 6181 1EyeScience 28TM 29 Announces New Program to Improve Patient Compliance and Practice Profits 6181 2EyeScience 28TM 29 Announces New Program to Improve Patient Compliance and Practice Profits 6181 3Understanding mechanical properties of silicon nanowires paves way for nanodevices 14797 1Understanding mechanical properties of silicon nanowires paves way for nanodevices 14797 2Older People at Greater Risk of Swine Flu Death 61188 1Older People at Greater Risk of Swine Flu Death 61188 2
...-(BUSINESS WIRE)--May 15, 2007 - Gemin X Biotechno...d in the journal Blood,demonstrated that its lead ... in vitro in Mantle Cell Lymphoma (MCL) cell lines... (GX15-070) is a small,molecule specifically desig...rotein family, a validated cancer target, thus res...
...technology reports positive results from placebo,c...om house dust,mite allergy , ,SCHLIEREN (Zurich), ... (SWX:CYTN) reported today positive results from a...dy with different formulations,of CYT003-QbG10, an...ment of allergic diseases. The study included 40 p...
Other Medicine Technology:Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7
(Date:11/26/2009)...wire/ -- The diabetes population in the United Sta...annual medical spending on the disease is projecte... according to a study published in the December is...abetes ® Program (NCDP), a program of Novo No...e University of Chicago. ,, According to the fo...
(Date:11/26/2009)...o strains or worse , , THURSDAY, Nov. 26...th stuffing your turkey full to bursting, but you ...case as you pack for holiday trips. , More than...al emergency rooms, doctors, offices, clinics and ...ies, such as muscle strains, pulls and tears, acco...
(Date:11/26/2009)... Live Life Again Center, a practice offering weig...mber of physicians who are taking advantage of po...viduals who are interested in surgical weight loss...lizing Facebook to share before-and-after photos a...ty. , Dallas, TX (Vocus) ...
(Date:11/26/2009)....A. is offering free nationwide confidential consu... pills who have suffered a Deep Vein Thrombosis (D...ther related cardiac issues or had their Gallbladd...6405 or go to the firm’s website at http://...uation form. , (PRWEB) No...
(Date:11/25/2009)...ewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.... will host two investor events in December: ,, ...a.m. CT/10:00 a.m. ET ,, Principal investigat...rfilzomib in relapsed and/or refractory multiple m...f Hematology (ASH) Annual Meeting and Exposition i...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...ser Comments on President Obama,s Town Hall Acknow...QUERQUE, N.M., May 15 Cody Unser, a 22-year-o... the Cody Unser First Step Foundation, commends Pr...for rapid acceleration of stem cell research so th...
...study techniques identify anti-inflammatory compon...Day News) -- Ginseng has been used in medicine for...ealth is expanding: A new study has found that the...even constituents of ginseng, called ginsenosides,...
..., May 15 The American Association of Clinical End...ology (AACE and ACE) today released a Position Sta...osition is a strong statement in support of contin...b ) , , The statement, shown below in its entiret...
...ecognized as the Most Effective Room Air Purifier ...., May 15 /PRNewswire/ -- IQAir North America, I...ture of superior air cleaning products, announced ...ests conducted by actual parents, the HealthPro Pl...
...O (May 15, 2009)Fox Chase Cancer Center researcher...ted with an earlier onset of prostate cancer in Ca...cancer. If the data are confirmed, the marker may ...rogram at Fox Chase, will present the data at the ...
...ny years, it has been known that aspirin is benefi...heart attacks. But which of the many different typ...up of researchers led by Dr. Sean Nordt from the U...egular aspirin chewed and swallowed, and chewable ...
Other Medicine News:Health News:Disability Activist Urges Obama to Escalate Stem Cell Research to End Paralysis For Millions of Americans 2Health News:New Discovery Shows Ancient Herb Fights Inflammation 2Health News:Major Physician Group Issues Statement in Support of Physician/Industry Relationships 2Health News:Major Physician Group Issues Statement in Support of Physician/Industry Relationships 3Health News:IQAir HealthPro Plus Wins Parent Tested Parent Approved Seal of Approval Award 2Health News:IQAir HealthPro Plus Wins Parent Tested Parent Approved Seal of Approval Award 3Health News:IQAir HealthPro Plus Wins Parent Tested Parent Approved Seal of Approval Award 4Health News:Genetic marker may predict early onset of prostate cancer 2
...IP joint or DIP joint flexion following injury or ...n comfort and softness, the breathable, foam-lined...allows for infinite adjustments to restore motion....FoamWrap™ splints are made with fabrifoam&re...
...y and control motion for persons with arthritis, a...due to stroke or cerebral palsy. Oval-8 splints ar... broad bands to comfortably distribute pressure. T...satile ring splint available. Whether using Oval-8...
Bariatric Knee Immobilizer
...nient, reusable, patient-friendly and effective al...opedic conditions/instabilities. These products ar...d lateral to medial influence of cutaneous nerve r...sue structures. Maximum benefit is accomplished by...
Medicine Products: